Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Higher Hematopoietic Cell Transplant Comorbidity Index (HCT-CI) Is Associated with Poor Psychosocial Health Pre-Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients

Pradnya D Patil, MD, Lisa Rybicki, MS, Donna Abounader, BBA, CCRP, Hien K. Liu, MD, Brian T. Hill, MD PhD, Robert Dean, MD, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Brad Pohlman, MD, Ronald Sobecks, MD, Brian J. Bolwell, MD, Matt Kalaycio, MD, Navneet S. Majhail, MD, Deepa Jagadeesh, MD MPH

Blood (2016) 128 (22): 4791.

https://doi.org/10.1182/blood.V128.22.4791.4791

Published: 2016

Journal Articles

Prognostic Effect of Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Cell Subsets on Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes

Sagar S. Patel, MD, Lisa Rybicki, MS, Donna Abounader, BBA, CCRP, Carol Dumont, MT, Brian J. Bolwell, MD, Robert Dean, MD, Priscilla Figueroa, MD, Rabi Hanna, MD, Hien K. Liu, MD, Aaron T. Gerds, MD MS, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH, Matt Kalaycio, MD, Kristin Ricci, MD, Ronald Sobecks, MD, Betty K. Hamilton, MD, Navneet S. Majhail, MD MS

Blood (2016) 128 (22): 660.

https://doi.org/10.1182/blood.V128.22.660.660

Published: 2016

Journal Articles

Prognostic Factors for Late Mortality Among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation (HCT)

Sagar S. Patel, MD, Lisa Rybicki, MS, Donna Abounader, BBA, CCRP, Brian J. Bolwell, MD, Robert Dean, MD, Hien K. Liu, MD, Aaron T. Gerds, MD MS, Rabi Hanna, MD, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH, Matt Kalaycio, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Navneet S. Majhail, MD MS, Betty K. Hamilton, MD

Blood (2016) 128 (22): 4666.

https://doi.org/10.1182/blood.V128.22.4666.4666

Published: 2016

Journal Articles

Comparative Effectiveness of Fludarabine and Busulfan Versus Fludarabine and 400 cGy Total Body Irradiation Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation for AML/MDS

Moaath Mustafa Ali, MD, Donna M Abounader, Lisa A. Rybicki, MS, Melissa A Yurch, Jamie Starn, RN, BSN, Christina Ferraro, RN, BSN, Victoria Winslow, RN, BSN, Betty K. Hamilton, MD, Aaron T. Gerds, MD MS, Hien Liu, MD, Robert Dean, Brian T. Hill, MD PhD, Brad Pohlman, MD, Steven Andresen, DO, Rabi Hanna, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS, Ronald Sobecks, MD

Blood (2015) 126 (23): 1920.

https://doi.org/10.1182/blood.V126.23.1920.1920

Published: 2015

Journal Articles

Lenalidomide and Rituximab Following Autologous Stem Cell Transplantation for B-Cell Non-Hodgkin Lymphoma Is Associated with Unacceptable Myelotoxicity

Robert Dean, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Amanda L. Maggiotto, BS, CCRP, Jennifer Bates, BS, CCRP, Stephen D. Smith, MD, Brian J. Bolwell, MD, John Sweetenham, MD

Blood (2011) 118 (21): 1621.

https://doi.org/10.1182/blood.V118.21.1621.1621

Published: 2011

Journal Articles

Poor Mobilization of CD34+ Stem Cells Predicts Inferior Relapse and Survival Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma

Aleksandr Lazaryan, MD, PhD, MPH, Hien Duong, MD, Lisa Rybicki, MS, Frederic J. Reu, MD, Robert Dean, MD, Ronald Sobecks, MD, Shawnda Tench, Edward A. Copelan, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD

Blood (2011) 118 (21): 3000.

https://doi.org/10.1182/blood.V118.21.3000.3000

Published: 2011

Journal Articles

A Proof of Principle Clinical Trial in Myelodysplastic Syndromes of Non-Cytotoxic Differentiation Therapy with Decitabine,

Yogen Saunthararajah, MD, Reda Z Mahfouz, MD, Ricki Englehaupt, Joy Juersivich, RN, MSc, Lisa Durkin, Tomas Radivoyevitch, PhD, Kathleen Cooper, RN, MSc, Manual Afable, MD, Robert Dean, Anjali S. Advani, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Edward A. Copelan, MD, Eric D. Hsi, MD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A Sekeres, MD

Blood (2011) 118 (21): 3830.

https://doi.org/10.1182/blood.V118.21.3830.3830

Published: 2011

Journal Articles

Neutropenic Fever During Stem Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Poor Survival Following Autologous Stem Cell Transplantation,

Hien Duong, MD, Brian J. Bolwell, MD, Lisa Rybicki, MS, John William Sweetenham, MD, Brad Pohlman, MD, Robert Dean, MD, Steven Andresen, DO, Matt Kalaycio, MD, Ronald Sobecks, MD, Anna Koo, MD, Edward A. Copelan, MD

Blood (2011) 118 (21): 4053.

https://doi.org/10.1182/blood.V118.21.4053.4053

Published: 2011

Journal Articles

Acute GVHD in AML and MDS Patients Receiving Matched Related Donor (MRD) Reduced-Intensity Conditioning Allogeneic Hematopoietic Progenitor Cell Transplant (RIC-AHPCT) Correlates with Major Histocompatibility Complex Class I-Related Molecule A (MICA) Gene Polymorphisms,

Ronald Sobecks, MD, Aiwen Zhang, Lisa Rybicki, MS, Dawn Thomas, BS, Paul Kawczak, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert Dean, MD, Edward A. Copelan, MD, Rabi Hanna, MD, Hien Duong, MD, Jaroslaw P. Maciejewski, MD, PhD, Brian J. Bolwell, MD, Medhat Askar, MD, PhD

Blood (2011) 118 (21): 4072.

https://doi.org/10.1182/blood.V118.21.4072.4072

Published: 2011

Journal Articles

Prognostic Significance of Bone Marrow Involvement At Diagnosis and At the Time of Autologous Stem Cell Transplantation for Lymphoma Relapse,

Aleksandr Lazaryan, MD, PhD, MPH, John Sweetenham, M.D., Lisa Rybicki, MS, Robert Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD, PhD, Hien Duong, Ronald Sobecks, MD, Steven Andresen, DO, Shawnda Tench, Matt Kalaycio, MD, Brian J. Bolwell, MD, Edward A. Copelan, MD

Blood (2011) 118 (21): 4122.

https://doi.org/10.1182/blood.V118.21.4122.4122

Published: 2011

Journal Articles

The Positive Effect of Inpatient Care-Partners During Allogeneic Bone Marrow Transplantation; A Prospective Trial

Linda McLellan, LISW, Larry Foster, Ph.D., Lisa Rybicki, MS, Jane Dabney, LISW, Michele Cooper, LISW, Hien Duong, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Edward A. Copelan, MD, Robert Dean, MD, Brad Pohlman, MD, Steven Andresen, DO, Shawnda Tench, Brian J. Bolwell, MD

Blood (2010) 116 (21): 931.

https://doi.org/10.1182/blood.V116.21.931.931

Published: 2010

Journal Articles

Analysis of Readmission After Autologous HCT: Predictive Factors and Clinical Consequences

Sanjay R. Mohan, MD, Lisa Rybicki, MS, Stephen D. Smith, MD, Robert Dean, MD, Brad Pohlman, MD, John William Sweetenham, MD, Matt Kalaycio, MD, Ronald Sobecks, MD, Steven Andresen, DO, Edward A. Copelan, MD, Brian J. Bolwell, MD

Blood (2010) 116 (21): 932.

https://doi.org/10.1182/blood.V116.21.932.932

Published: 2010

Journal Articles

Comparison of Single Versus Multiple Unit Umbilical Cord Blood Transplantation for Adult Hematologic Malignancy Patients

Ronald Sobecks, MD, Edward A. Copelan, MD, Matt Kalaycio, MD, Medhat Askar, MD, PhD, Lisa Rybicki, MS, Sheila Serafino, Mary Serafin, Robert Dean, MD, Brad Pohlman, MD, Steven Andresen, DO, Brian J. Bolwell, MD

Blood (2010) 116 (21): 3545.

https://doi.org/10.1182/blood.V116.21.3545.3545

Published: 2010

Journal Articles

Intravenous Compared to Oral Busulfan with Cyclophophamide for Allogeneic Hematopoietic Progenitor Cell Transplant Conditioning for AML and MDS.

Ronald Sobecks, MD, Lisa Rybicki, MS, Matt Kalaycio, MD, Robert Dean, MD, Steven Andresen, DO, Brad Pohlman, MD, Brian J. Bolwell, MD, Edward A. Copelan, MD

Blood (2010) 116 (21): 3475.

https://doi.org/10.1182/blood.V116.21.3475.3475

Published: 2010

Journal Articles

Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation.

Nelli Bejanyan, MD, Aleksandr Lazaryan, MD, PhD, MPH, Lisa Rybicki, MS, Shawnda Tench, Steven Andresen, DO, Ronald Sobecks, MD, Robert Dean, MD, Brad Pohlman, MD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Edward A. Copelan, MD

Blood (2010) 116 (21): 1532.

https://doi.org/10.1182/blood.V116.21.1532.1532

Published: 2010

Journal Articles

Higher Non-Relapse Mortality with BuCyVP Compared to BuCy In Allogeneic Hematopoietic Stem Cell Transplant

Hien Duong, MD, Brian J. Bolwell, MD, Lisa Rybicki, MS, Matt Kalaycio, MD, Steven Andresen, DO, Ronald Sobecks, MD, Robert Dean, MD, John William Sweetenham, MD, FRCP, Shawnda Tench, Edward A. Copelan, MD

Blood (2010) 116 (21): 1340.

https://doi.org/10.1182/blood.V116.21.1340.1340

Published: 2010

Journal Articles

Bortezomib for ITP: First Report of Successful Treatment of Refractory ITP In a Patient with Otherwise Asymptomatic Monoclonal Gammopathy

Aleksandr Lazaryan, MD, MPH, PhD, Alan E. Lichtin, MD, Keith R McCrae, M.D., Janice Reed, RN, Robert Dean, MD, Claudiu Cotta, MD, Frederic J. Reu, MD

Blood (2010) 116 (21): 4667.

https://doi.org/10.1182/blood.V116.21.4667.4667

Published: 2010

Journal Articles

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Aleksandr Lazaryan, MD, MPH, PhD, Rachid Baz, MD, Mohamad A Hussein, Jr, MD, Paul Elson, ScD, Beth Faiman, CNP, Becky Habecker, Mary Ann Karam, RN, Janice Reed, RN, Kimberly Hamilton, RN, Kellie Bruening, Gordan Srkalovic, MD, PhD, Steven Andresen, DO, Matt Kalaycio, MD, John William Sweetenham, MD, FRCP, Ronald Sobecks, MD, Robert Dean, MD, Robert Knight, MD, Jerome B. Zeldis, MD, PhD, Frederic J. Reu, MD

Blood (2010) 116 (21): 1967.

https://doi.org/10.1182/blood.V116.21.1967.1967

Published: 2010

Journal Articles

Older Patients with AML Undergoing Matched Related Allogeneic Transplantation Have Significantly Older Donors but Equivalent Survival as Patients Receiving Unrelated Donor Transplants

Brian T. Hill, MD, PhD, Lisa Rybicki, MS, Brian J. Bolwell, MD, Robert Dean, MD, Brad Pohlman, MD, Shawnda Tench, Ronald Sobecks, MD, Steven Andresen, DO, Edward A. Copelan, MD, Matt Kalaycio, MD

Blood (2010) 116 (21): 2356.

https://doi.org/10.1182/blood.V116.21.2356.2356

Published: 2010

Journal Articles

Cigarette Smoking Is Associated with Increased Rates of Fungal Infection and Increased Mortality After Allogeneic Transplantation

Brian T. Hill, MD, PhD, Brian J. Bolwell, MD, Lisa Rybicki, MS, Mikkael A. Sekeres, MD, MS, Mary Mansour, DO, Robert Dean, MD, Brad Pohlman, MD, Shawnda Tench, Ronald Sobecks, MD, Steven Andresen, DO, Matt Kalaycio, MD, Edward A. Copelan, MD

Blood (2010) 116 (21): 2321.

https://doi.org/10.1182/blood.V116.21.2321.2321

Published: 2010

NARROW

Higher Hematopoietic Cell Transplant Comorbidity Index (HCT-CI) Is Associated with Poor Psychosocial Health Pre-Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients

Prognostic Effect of Bone Marrow (BM) and Peripheral Blood Stem Cell (PBSC) Donor Cell Subsets on Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes

Prognostic Factors for Late Mortality Among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation (HCT)

Comparative Effectiveness of Fludarabine and Busulfan Versus Fludarabine and 400 cGy Total Body Irradiation Reduced Intensity Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation for AML/MDS

Lenalidomide and Rituximab Following Autologous Stem Cell Transplantation for B-Cell Non-Hodgkin Lymphoma Is Associated with Unacceptable Myelotoxicity

Poor Mobilization of CD34+ Stem Cells Predicts Inferior Relapse and Survival Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma

A Proof of Principle Clinical Trial in Myelodysplastic Syndromes of Non-Cytotoxic Differentiation Therapy with Decitabine,

Neutropenic Fever During Stem Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Poor Survival Following Autologous Stem Cell Transplantation,

Acute GVHD in AML and MDS Patients Receiving Matched Related Donor (MRD) Reduced-Intensity Conditioning Allogeneic Hematopoietic Progenitor Cell Transplant (RIC-AHPCT) Correlates with Major Histocompatibility Complex Class I-Related Molecule A (MICA) Gene Polymorphisms,

Prognostic Significance of Bone Marrow Involvement At Diagnosis and At the Time of Autologous Stem Cell Transplantation for Lymphoma Relapse,

The Positive Effect of Inpatient Care-Partners During Allogeneic Bone Marrow Transplantation; A Prospective Trial

Analysis of Readmission After Autologous HCT: Predictive Factors and Clinical Consequences

Comparison of Single Versus Multiple Unit Umbilical Cord Blood Transplantation for Adult Hematologic Malignancy Patients

Intravenous Compared to Oral Busulfan with Cyclophophamide for Allogeneic Hematopoietic Progenitor Cell Transplant Conditioning for AML and MDS.

Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation.

Higher Non-Relapse Mortality with BuCyVP Compared to BuCy In Allogeneic Hematopoietic Stem Cell Transplant

Bortezomib for ITP: First Report of Successful Treatment of Refractory ITP In a Patient with Otherwise Asymptomatic Monoclonal Gammopathy

Mature Results of MM011: A Phase I/II Trial of Lenalidomide, Liposomal Doxorubicin, Dexamethasone, and Vincristine, Followed by Lenalidomide Maintenance (DVd-R) for Relapsed or Refractory Multiple Myeloma

Older Patients with AML Undergoing Matched Related Allogeneic Transplantation Have Significantly Older Donors but Equivalent Survival as Patients Receiving Unrelated Donor Transplants

Cigarette Smoking Is Associated with Increased Rates of Fungal Infection and Increased Mortality After Allogeneic Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only